Article
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
Journal of the National Cancer Institute - 5 May 2010
Azzato Elizabeth M, Tyrer Jonathan, Fasching Peter A, Beckmann Matthias W, Ekici Arif B, Schulz-Wendtland Rüdiger, Bojesen Stig E, Nordestgaard Børge G, Flyger Henrik, Milne Roger L, Arias José Ignacio, Menéndez Primitiva, Benítez Javier, Chang-Claude Jenny, Hein Rebecca, Wang-Gohrke Shan, Nevanlinna Heli, Heikkinen Tuomas, Aittomäki Kristiina, Blomqvist Carl, Margolin Sara, Mannermaa Arto, Kosma Veli-Matti, Kataja Vesa, Beesley Jonathan, Chen Xiaoqing, Chenevix-Trench Georgia, Couch Fergus J, Olson Janet E, Fredericksen Zachary S, Wang Xianshu, Giles Graham G, Severi Gianluca, Baglietto Laura, Southey Melissa C, Devilee Peter, Tollenaar Rob A E M, Seynaeve Caroline, García-Closas Montserrat, Lissowska Jolanta, Sherman Mark E, Bolton Kelly L, Hall Per, Czene Kamila, Cox Angela, Brock Ian W, Elliott Graeme C, Reed Malcolm W R, Greenberg David, Anton-Culver Hoda, Ziogas Argyrios, Humphreys Manjeet, Easton Douglas F, Caporaso Neil E, Pharoah Paul D P
Abstract excerpt
BACKGROUND: Traditional prognostic factors for survival and treatment response of patients with breast cancer do not fully account for observed survival variation. We used available genotype data from a previously conducted two-stage, breast cancer susceptibility genome-wide association study (ie, Studies of Epidemiology and Risk factors in Cancer Heredity [SEARCH]) to investigate associations between variation...
Read the complete abstract on PubMed